Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$223M |
| 2 |
CVS Health
CVS
|
+$18.9M |
| 3 |
American International
AIG
|
+$16.3M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$13.4M |
| 5 |
TJX Companies
TJX
|
+$12.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$12.6M |
| 2 |
Crown Castle
CCI
|
+$7.91M |
| 3 |
Eli Lilly
LLY
|
+$7.58M |
| 4 |
RTX Corp
RTX
|
+$7.28M |
| 5 |
Deere & Co
DE
|
+$7.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.16% |
| 2 | Consumer Discretionary | 11.77% |
| 3 | Financials | 11.5% |
| 4 | Healthcare | 9.84% |
| 5 | Technology | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
IO
1001
DELISTED
ION Geophysical Corporation
IO
| $69K | ﹤0.01% |
+11,100
| New | +$83.1K |
2016 Q2
0 quarters
|
|
|
IIP
1002
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
| $69K | ﹤0.01% |
+33,500
| New | +$69K |
2016 Q2
0 quarters
|
|
1003
Uranium Energy
UEC
$3.79B
| $67K | ﹤0.01% |
+76,700
| New | +$63.6K |
2016 Q2
0 quarters
|
|
|
SQNM
1004
DELISTED
SEQUENOM INC NEW
SQNM
| $67K | ﹤0.01% |
73,400
+16,600
| +29% | +$19.8K |
2015 Q4
2 quarters
|
|
1005
McEwen Inc
MUX
$855M
| $65K | ﹤0.01% |
+1,700
| New | +$45K |
2016 Q2
0 quarters
|
|
|
ATRS
1006
DELISTED
Antares Pharma, Inc.
ATRS
| $65K | ﹤0.01% |
+61,900
| New | +$59.8K |
2016 Q2
0 quarters
|
|
|
GLUU
1007
DELISTED
Glu Mobile Inc.
GLUU
| $65K | ﹤0.01% |
+29,600
| New | +$74.5K |
2016 Q2
0 quarters
|
|
|
SKUL
1008
DELISTED
SKULLCANDY INC
SKUL
| $65K | ﹤0.01% |
+10,600
| New | +$41.9K |
2016 Q2
0 quarters
|
|
|
KEG
1009
DELISTED
KEY ENERGY SERVICES INC
KEG
| $65K | ﹤0.01% |
+281,200
| New | +$65K |
2016 Q2
0 quarters
|
|
|
CJES
1010
DELISTED
C&J ENERGY SVCS LTD
CJES
| $64K | ﹤0.01% |
+106,500
| New | +$99.2K |
2016 Q2
0 quarters
|
|
1011
Enphase Energy
ENPH
$4B
| $63K | ﹤0.01% |
+31,500
| New | +$69.2K |
2016 Q2
0 quarters
|
|
|
SNMX
1012
DELISTED
Senomyx, Inc.
SNMX
| $63K | ﹤0.01% |
+23,000
| New | +$61.7K |
2016 Q2
0 quarters
|
|
|
VVUS
1013
DELISTED
Vivus Inc
VVUS
| $63K | ﹤0.01% |
+5,640
| New | +$77.9K |
2016 Q2
0 quarters
|
|
1014
Harte-Hanks
HHS
$29.7M
| $62K | ﹤0.01% |
+3,930
| New | +$69.4K |
2016 Q2
0 quarters
|
|
1015
CPI Card Group
PMTS
$287M
| $62K | ﹤0.01% |
+2,480
| New | +$76.4K |
2016 Q2
0 quarters
|
|
|
ALR
1016
DELISTED
AlerisLife Inc
ALR
| $61K | ﹤0.01% |
+2,610
| New | +$56.3K |
2016 Q2
0 quarters
|
|
1017
First Bancorp
FBP
$4B
| $59K | ﹤0.01% |
14,896
-14,279
| -49% | -$53.6K |
2016 Q1
1 quarter
|
|
|
INFI
1018
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $58K | ﹤0.01% |
43,690
-23,410
| -35% | -$109K |
2015 Q4
2 quarters
|
|
1019
DELISTED
Christopher & Banks Corporation
CBK
| $58K | ﹤0.01% |
+26,300
| New | +$61K |
2016 Q2
0 quarters
|
|
|
NWBO
1020
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| $58K | ﹤0.01% |
+100,200
| New | +$107K |
2016 Q2
0 quarters
|
|
|
UNIS
1021
DELISTED
Unilife Corporation
UNIS
| $56K | ﹤0.01% |
+17,000
| New | +$74.4K |
2016 Q2
0 quarters
|
|
1022
DELISTED
Xoma
XOMA
| $54K | ﹤0.01% |
+4,905
| New | +$70.3K |
2016 Q2
0 quarters
|
|
1023
Energy Fuels
UUUU
$1.96B
| $52K | ﹤0.01% |
+22,900
| New | +$53.2K |
2016 Q2
0 quarters
|
|
|
ARNA
1024
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $52K | ﹤0.01% |
+3,040
| New | +$54.3K |
2016 Q2
0 quarters
|
|
|
DRNA
1025
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $49K | ﹤0.01% |
+16,300
| New | +$66.9K |
2016 Q2
0 quarters
|
|
Similar funds
Squarepoint's Q2 2016 Portfolio in Review
As of Q2 2016, Squarepoint held 1,549 positions worth $1.6B, up 24% from $1.29B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Squarepoint deployed $307M of net new capital in Q2 2016, opening 435 new positions and adding to 314 existing holdings. Its largest new stake was State Street SPDR S&P MIDCAP 400 ETF Trust: 833,964 shares worth $227M.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 2.8% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Crown Castle, an estimated $7.91M trimmed.
- Squarepoint's largest Q2 2016 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 833,964 shares worth $227M.
- Squarepoint added most to CVS Health in Q2 2016, an estimated $18.9M increase.
- Squarepoint's biggest Q2 2016 reduction was Crown Castle, cutting an estimated $7.91M.
- Squarepoint fully exited Chubb in Q2 2016, selling an estimated $12.6M.
- Squarepoint's ten largest holdings make up 23% of its $1.6B portfolio in Q2 2016.
- Squarepoint opened 435 new positions and closed 482 in Q2 2016.
- Squarepoint's portfolio value rose 24% quarter-over-quarter to $1.6B.
Based on Squarepoint's 13F filing for Q2 2016, filed 15 Aug 2016.